Radiotherapy of Grade III Gliomas : Identification of Clinical Prognostic Factors for Local Tumor Control and Survival
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved..
BACKGROUND/AIM: The prognoses of patients with grade III gliomas require improvement, which may be achieved with personalized care. We aimed to identify prognostic factors to facilitate the process of treatment personalization.
PATIENTS AND METHODS: Eight factors were analyzed for local tumor control and survival in 44 patients irradiated for grade III glioma. These factors included location and size of glioma, number of glioma sites, performance status, gender, age, neurosurgical intervention and chemotherapy.
RESULTS: In the Cox regression analyses, frontal location (risk ratio=4.41, p=0.048) and unifocal glioma (risk ratio=4.65, p=0.034) were associated with improved local control, and unifocal glioma with improved survival (risk ratio=6.12, p=0.033). In addition, trends for better survival were observed for frontal location (p=0.093), age ≤49 years (p=0.070), upfront resection (p=0.099) and chemotherapy (p=0.066) on univariate analyses.
CONCLUSION: Independent predictors of local tumor control and survival were identified that can be helpful for personalizing treatment and designing clinical trials.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
In vivo (Athens, Greece) - 34(2020), 6 vom: 03. Nov., Seite 3627-3630 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rades, Dirk [VerfasserIn] |
---|
Links: |
---|
Themen: |
Grade III glioma |
---|
Anmerkungen: |
Date Completed 18.06.2021 Date Revised 18.06.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.21873/invivo.12208 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM317127357 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM317127357 | ||
003 | DE-627 | ||
005 | 20231225162605.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.21873/invivo.12208 |2 doi | |
028 | 5 | 2 | |a pubmed24n1057.xml |
035 | |a (DE-627)NLM317127357 | ||
035 | |a (NLM)33144477 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rades, Dirk |e verfasserin |4 aut | |
245 | 1 | 0 | |a Radiotherapy of Grade III Gliomas |b Identification of Clinical Prognostic Factors for Local Tumor Control and Survival |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.06.2021 | ||
500 | |a Date Revised 18.06.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. | ||
520 | |a BACKGROUND/AIM: The prognoses of patients with grade III gliomas require improvement, which may be achieved with personalized care. We aimed to identify prognostic factors to facilitate the process of treatment personalization | ||
520 | |a PATIENTS AND METHODS: Eight factors were analyzed for local tumor control and survival in 44 patients irradiated for grade III glioma. These factors included location and size of glioma, number of glioma sites, performance status, gender, age, neurosurgical intervention and chemotherapy | ||
520 | |a RESULTS: In the Cox regression analyses, frontal location (risk ratio=4.41, p=0.048) and unifocal glioma (risk ratio=4.65, p=0.034) were associated with improved local control, and unifocal glioma with improved survival (risk ratio=6.12, p=0.033). In addition, trends for better survival were observed for frontal location (p=0.093), age ≤49 years (p=0.070), upfront resection (p=0.099) and chemotherapy (p=0.066) on univariate analyses | ||
520 | |a CONCLUSION: Independent predictors of local tumor control and survival were identified that can be helpful for personalizing treatment and designing clinical trials | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Grade III glioma | |
650 | 4 | |a irradiation | |
650 | 4 | |a local tumor control | |
650 | 4 | |a neurosurgical intervention | |
650 | 4 | |a survival | |
700 | 1 | |a Witteler, Jaspar |e verfasserin |4 aut | |
700 | 1 | |a Schild, Steven E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t In vivo (Athens, Greece) |d 1992 |g 34(2020), 6 vom: 03. Nov., Seite 3627-3630 |w (DE-627)NLM012776912 |x 1791-7549 |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2020 |g number:6 |g day:03 |g month:11 |g pages:3627-3630 |
856 | 4 | 0 | |u http://dx.doi.org/10.21873/invivo.12208 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 34 |j 2020 |e 6 |b 03 |c 11 |h 3627-3630 |